Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Buprenorphine / Naloxone and Buprenorphine Sublingual Formulations for Opioid Dependence. Criteria for Use for Office-Based Opioid Treatment (OBOT) Settings.

VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives with, Gordon AJ, Kivlahan D, Liberto J, McNicholas L, Oslin DW, Saxon A, Trafton J. Buprenorphine / Naloxone and Buprenorphine Sublingual Formulations for Opioid Dependence. Criteria for Use for Office-Based Opioid Treatment (OBOT) Settings. 2013 Apr 1.



Abstract:

Buprenorphine Sublingual Criteria. www.pbm.va.gov/clinicalguidance/criteriaforuse/BuprenorphineSublingualCriteriaforUse.pdf (Washington, DC: US Department of Veterans Affairs)




Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.